Author

Gilles Roussine Codo

Centre National de la Recherche ScientifiquePrimary ORCID profile (0009-0008-6652-4962 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Gilles Roussine CodoiD1 paper · Centre National de la Recherche Scientifique

Biology Disciplines

Click to filter author papers

Pathology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2

Frequent Co-Authors

Christophe SiraciD· 2 shared Gemma Martinez-RivasiD· 2 shared Sébastien BenderiD· 2 shared Alan C. StuckeyiD· 1 shared Alessio LampisiD· 1 shared Andrew Vick· 1 shared Angela D. Williams· 1 shared Arnaud JaccardiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

Christophe SiracORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Preclinical characterization of AT-03, a novel Serum Amyloid P fusion protein that demonstrates pan-amyloid binding and removal

Christophe Sirac, Gilles Roussine Codo, Arnaud Jaccard, Sébastien Bender, Gemma Martinez-Rivas, Frank Bridoux, Marie Clavel, Camille Villesuzanne, Oussama Taoui, Claire Carrion, Gregory Bell, Spencer D. Guthrie, Suganya Selvarajah, Andrew Vick, Stephen J. Kennel, , Jonathan S. Wall

This paper characterizes AT-03, a novel fusion protein that binds and removes various amyloid types, showing therapeutic efficacy in a mouse model.

bioRxiv · Dec 25, 2025 · PreprintPathology

Accelerated Apolipoprotein A-II senile amyloidosis in a PAI-1 (plasminogen activator inhibitor 1) knock-out model

Gilles Roussine Codo, Pauline Duchatelet, Gemma Martinez-Rivas, Alessio Lampis, Karolina Weronika Świderska, Émilie Pinault, Camille Cohen, Magali Colombat, Sébastien Bender, Christophe Sirac

This study shows PAI-1 knockout mice develop systemic AApoA-II amyloidosis at intermediate age, with amyloid deposits in multiple organs and urinary albumin as a biomarker, highlighting potential risks of PAI-1 inhibition in amyloidosis.

bioRxiv · Dec 23, 2025 · PreprintPathology